参考文献/References:
[1]Chiu C,Legrand M.Epidemiology of sepsis and septic shock[J].Curr Opin Anaesthesiol,2021,34(2):71-76.[2]Weng L,Xu Y,Yin P,et al.National incidence and mortality of hospitalized sepsis in China[J].Crit Care,2023,27(1):84.[3]顾晓霞,高振军.溃疡性结肠炎患者肠道菌群失调与H.pylori感染和DAI评分及免疫球蛋白水平的相关性[J].中国微生态学杂志,2023,35(3):348-352.[4]杨银娟,尚亚楠,尚向涛.脓毒症患者肠道细菌紊乱与炎性细胞因子及T淋巴细胞亚群的相关性[J].中国急救复苏与灾害医学杂志,2020,15(9):1092-1095[5]Zhao DN,Li SL,Cui J,et al.Plasma miR-125a and miR-125b insepsis: correlation with disease risk, inflammation, severity,and prognosis[J].J Clin Lab Anal,2020,34(2):e23036.[6]中国医师协会急诊医师分会,中国研究型医院学会休克与脓毒症专业委员会.中国脓毒症/脓毒性休克急诊治疗指南(2018)[J].中国急救医学,2018,38(9):741-756.[7]李超,李妮妮,吕红霞,等.微小RNA-122a、微小RNA-133a-3P与脓毒症患者严重程度、预后的关系[J].中国临床医生杂志,2022,50(5):586-588.[8]赵娜,赵宁,申晓楠,等.脓毒症患者的凝血功能、炎症因子变化及其与病情严重程度和预后的相关性[J].海南医学,2024,35(6):844-848.[9]陈君,王妮,陈栩栩,等.ICU脓毒症患者血清Presepsin、内毒素、IL-6、PCT水平与预后的相关性[J].中华医院感染学杂志,2022,32(3):356-359.[10]张赟,陈娟,黄尧米.血浆Th1/Th2细胞、ET、PTA、PCT与脓毒症患儿病情严重程度及转归的关系分析[J].河北医科大学学报,2022,43(12):1449-1453.[11]余广炜,林增杰,涂福泉,等.中性粒细胞/淋巴细胞比值联合随机血糖对脓毒症预测价值[J].中华急诊医学杂志,2024,33(5):636-642.[12]龚广欣,杨坷,赵里曼.尿毒症性脑病的危险因素及相关炎症因子的预测价值[J].中国卫生检验杂志,2020,30(15):1905-1907.[13]Liu YM,Pan GHR.Research progress on the pathogenesis of acute lung injury in sepsis[J].hinese Journal of Difficult and Complicated Cases,2022,21(8):868-871,876.[14]于欢,张秀丽.外周血感染性指标IL-6联合NLR评估脓毒血症患者病情的临床价值[J].中国预防医学杂志,2022,21(10):1120-1124.[15]郑承全.系统免疫炎症指数联合预后营养指数在评价脓毒症患者病情及预后应用价值[D].南昌:昌大学,2022. [16]潘树滨,张芳晓,马晓春,等.中性粒细胞/淋巴细胞比值早期预测脓毒症器官功能损伤及28 d 病死率的临床价值[J].中华危重病急救医学,2021,33(6):665-670.[17]马占一,李传贵,张敬红,等.CRP、PCT、NLR联合检测预警输尿管结石发生尿源性脓毒血症的临床研究 [J].陆军军医大学学报,2022,44(6):589-594.[18]左扬松,周素芹,王丽莉,等.脓毒症相关急性肺损伤患者趋化因子受体4、可溶性髓样细胞触发受体样转录因子-1检测价值探讨[J].实用医院临床杂志,2023,20(6):84-86.[19]Wang Q,Liu K,Jin C.Clinical value of micro RNA-378a-3p in sepsis and its role in sepsis-induced inflammation and cardiac dysfunction[J].Bioengineered,2021,12(1):8496-8504.[20]奚耀,赵雷,钱风华,等.老年脓毒症患者红细胞分布宽度与病情程度的相关性[J].实用临床医药杂志,2021,25(16):112-115.
相似文献/References:
[1]李安乐,戴 夫,彭 琼.中性粒细胞与淋巴细胞比值、红细胞体积分布宽度与乙型肝炎及乙型肝炎肝硬化的关系研究[J].医学信息,2019,32(03):69.[doi:10.3969/j.issn.1006-1959.2019.03.022]
LI An-le,DAI Fu,PENG Qiong.Relationship between Neutrophil-lymphocyte Ratio,Red Blood Cell Volume Distribution Width and Hepatitis B and Hepatitis B Cirrhosis[J].Journal of Medical Information,2019,32(06):69.[doi:10.3969/j.issn.1006-1959.2019.03.022]
[2]张凯新,杨林瀛.不同嗜酸性粒细胞水平的慢性阻塞性肺疾病急性加重期患者临床分析[J].医学信息,2021,34(08):85.[doi:10.3969/j.issn.1006-1959.2021.08.022]
ZHANG Kai-xin,YANG Lin-ying.Clinical Analysis of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Different Levels of Eosinophils[J].Journal of Medical Information,2021,34(06):85.[doi:10.3969/j.issn.1006-1959.2021.08.022]
[3]侯 旭,戴 夫,彭 琼.RDW和NLR联合检测在胃癌诊断中的价值[J].医学信息,2021,34(08):175.[doi:10.3969/j.issn.1006-1959.2021.08.049]
HOU Xu,DAI Fu,PENG Qiong.The Value of Combined Detection of RDW and NLR in the Diagnosis of Gastric Cancer[J].Journal of Medical Information,2021,34(06):175.[doi:10.3969/j.issn.1006-1959.2021.08.049]
[4]刘 杰,贾 志.NLR、RBP-4及MPV与不稳定型心绞痛患者冠状动脉病变程度的相关性分析[J].医学信息,2022,35(03):91.[doi:10.3969/j.issn.1006-1959.2022.03.021]
LIU Jie,JIA Zhi.Correlation Analysis of NLR, RBP-4 and MPV with Coronary Artery Lesionsin Patients with Unstable Angina Pectoris[J].Journal of Medical Information,2022,35(06):91.[doi:10.3969/j.issn.1006-1959.2022.03.021]
[5]董圆振,夏 昆,吴云虎.颅内动脉瘤患者血NLR变化特点及其与Hunt-Hess评分的相关性分析[J].医学信息,2022,35(08):101.[doi:10.3969/j.issn.1006-1959.2022.08.024]
DONG Yuan-zhen,XIA Kun,WU Yun-hu.The Characteristics of Neutrophil to Lymphocyte Ratio Changes in Patients with Intracranial Aneurysm and its Correlation with Hunt-Hess Score[J].Journal of Medical Information,2022,35(06):101.[doi:10.3969/j.issn.1006-1959.2022.08.024]
[6]石绣江,朱海艳,梁晓萍,等.基于NLR建立列线图模型预测肝硬化门静脉血栓形成风险[J].医学信息,2024,37(18):29.[doi:10.3969/j.issn.1006-1959.2024.18.004]
SHI Xiu-jiang,ZHU Hai-yan,LIANG Xiao-ping,et al.Establishment of Nomograph Model Based on NLR to Predict the Risk of Portal Vein Thrombosis in Liver Cirrhosis[J].Journal of Medical Information,2024,37(06):29.[doi:10.3969/j.issn.1006-1959.2024.18.004]